Skip to main content

Month: July 2020

Aura Minerals Announces Second Quarter 2020 Earnings Call

ROAD TOWN, British Virgin Islands, July 30, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (“Aura” or the “Company”) today announced it will report its financial and operating results for the second quarter and first half of 2020 after the market closes on Wednesday, August 5, 2020. Aura will subsequently hold a conference call at 9:00 a.m. Eastern Time on Thursday, August 6, 2020 to discuss the results. Those wishing to join the call can do so using the information posted below.Conference Call DetailsDate: Thursday, August 6, 2020, 9:00 a.m. Eastern TimeToll Free Dial-In Number: +1 844 204-8942International Callers: +1 412 717-9627 or +55 11 4210-1803 (Brazil)Webcast: in English: https://webcastlite.mziq.com/cover.html?webcastId=19a76729-683f-4b50-83a2-3999954739b6 andin Portuguese: https://webcastlite.mziq.com/cover.html?webcastId=6b176f9e-756b-43cd-8ad9-6ac95c302b1bThe...

Continue reading

Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results

MELBOURNE, Australia, July 30, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive results from the two-year follow-up of patients enrolled in the Phase 1 clinical trial of CYP-001, Cynata’s lead induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal stem cell (MSC) product. The Phase 1 trial, which was the world’s first clinical trial of an allogeneic iPSC-derived MSC product, evaluated the safety and efficacy of CYP-001 for the treatment of patients with steroid-resistant acute graft-versus-host disease (GvHD).Highlights:Overall survival after two years was 60% (9/15 patients), which compares favourably to previously published outcomes in this patient populationNo treatment-related...

Continue reading

ABM Industries Names Chief Information Officer

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced Melanie Kirkwood Ruiz as the Company’s Chief Information Officer, reporting directly to ABM’s Chief Strategy and Transformation Officer, Josh Feinberg.Melanie joined ABM from Cushman & Wakefield, where she was responsible for developing the technology strategy in the Americas, and oversaw the change agenda focused on innovation, integration and optimization. She is a progressive technology leader with 20 years of experience across diverse industries including technology, commercial real estate, manufacturing, healthcare and aviation. “We’re thrilled to have Melanie on the ABM team,” said Mr. Feinberg. “Her skill set and experience spans a range of industries, many of which align with ABM’s end-markets. Under her leadership,...

Continue reading

Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference

FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 40th Annual Canaccord Genuity Growth Conference. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Misonix Chief Financial Officer, will be making a virtual company presentation on Wednesday, August 12th at 10:30 a.m. ET. Management will also be available to speak with institutional investors in one-on-one virtual meetings throughout the day on August 12th and 13th.If you have questions about Misonix or are interested in conducting a conference call or meeting with management, please contact the Company’s investor relations firm, JCIR, at (212)...

Continue reading

The First of Long Island Corporation Reports Earnings for the Second Quarter of 2020

GLEN HEAD, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC), the parent company of The First National Bank of Long Island, reported net income and earnings per share for the three and six months ended June 30, 2020.  In the highlights that follow, all comparisons are of the current three or six-month period to the same period last year unless otherwise indicated.SECOND QUARTER HIGHLIGHTSNet Income and EPS were $10.8 million and $.45, respectively, compared to $10.7 million and $.43ROA and ROE were 1.02% and 11.30%, respectively, compared to 1.02% and 11.00%Net interest margin was 2.64% versus 2.58%Cost of interest-bearing deposits declined 51 basis points to .96% and cost of interest-bearing liabilities declined 43 basis points to 1.14%Cash Dividends Per Share increased 5.9% to $.18 from $.17Provided...

Continue reading

X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Presentation of positive clinical data at EHA 2020 supporting the ongoing Phase 3 trial in WHIM syndromeInitial data expected later this year from Phase 1b clinical trial in Waldenström’s macroglobulinemiaConference call today at 8:30 a.m. ETCAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today reported financial results for the second quarter ended June 30, 2020. The company also provided an update on its lead investigational candidate, mavorixafor, a novel small molecule in a Phase 3 clinical trial for patients with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome and in two Phase 1b trials in patients with Waldenström’s macroglobulinemia...

Continue reading

Integer Holdings Corporation Reports Second Quarter 2020 Results

PLANO, Texas, July 30, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended July 3, 2020.  Unless otherwise stated, all results and comparisons are from continuing operations.Leading through the “new normal” of COVID-19COVID-19 safety measures are in place for Integer associates, who continue to deliver critical products that customers and patients rely on every day.Integer is treating the current environment as the “new normal” by increasing its agility to respond to changing customer demand and adjusting costs related to the expected temporary volume decline.Integer continues to execute its operational strategic imperatives to create long-term value.Integer is positioned to continue making strategic investments in capabilities...

Continue reading

Nano Dimension Announces Second Quarter 2020 Conference Call

Nano Dimension’s USA HQ, Boca Raton, Florida, July 30, 2020 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), a leading Additively Manufactured Electronics (AME)/PE (Printed Electronics) provider, today announced that it will release its full results for the second quarter of 2020 before the Nasdaq market opens on Thursday, August 13, 2020. Mr. Yoav Stern, President and Chief Executive Officer, and Ms. Yael Sandler, Chief Financial Officer, will host a conference call on August 13, 2020, at 9:00 a.m. ET, to discuss the financial results. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number. U.S. Dial-in...

Continue reading

Capital Power reports solid second quarter 2020 results, announces a 6.8% dividend increase for its common shares, and the Strathmore Solar project

EDMONTON, Alberta, July 30, 2020 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended June 30, 2020.HighlightsGenerated net cash flows from operating activities of $91 million and adjusted funds from operations (AFFO) of $97 million in the second quarter of 2020Generated net income of $23 million and adjusted EBITDA of $217 million in the second quarter of 2020Proceeding with the Strathmore Solar project that will add 40.5 megawatts in early 2022Proceeding with the third phase of the Whitla Wind facility that will add 54 megawatts in late 2021Capital Power Executive team realigned for the futureIncreased the common share dividend by 6.8% to $2.05 per year representing the seventh consecutive annual increase“Capital Power’s financial results in the second quarter of 2020 were...

Continue reading

Carpenter Technology Reports Fourth Quarter and Fiscal Year 2020 Results

Generated $137 million of operating cash flow; free cash flow of $100 millionTotal liquidity of $417 million including $193 million of cash on handExecuted portfolio and cost initiatives expected to deliver $60-$70 million in annual cost savingsPHILADELPHIA, July 30, 2020 (GLOBE NEWSWIRE) — Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal fourth quarter and year ended June 30, 2020. For the quarter, the Company reported a net loss of $118.4 million, or $2.46 loss per diluted share. Excluding special items, adjusted loss per diluted share was $0.31 in the quarter.“We generated strong free cash flow in the quarter which further strengthened our already healthy liquidity position via a significant reduction in inventory,” said Tony R. Thene, President and CEO of Carpenter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.